. CSF p-tau as a potential cognition impairment biomarker in ALS. Front Neurol. 2022;13:991143. Epub 2022 Nov 1 PubMed. RETRACTED

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics